Trexquant Investment LP Viracta Therapeutics, Inc. Transaction History

Trexquant Investment LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.23 - $4.76 $67,033 - $143,085	-30,060 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.37 - $7.91 $63,804 - $149,760	18,933 Added 170.15%	30,060 $110,000
Q3 2021 Nov 12, 2021	BUY	$7.84 - $12.53 $6,177 - $9,873	788 Added 7.62%	11,127 $89,000
Q2 2021 Aug 12, 2021	BUY	$7.55 - $12.95 $78,059 - $133,890	10,339 New	10,339 $117,000

5.63M

Ticker VIRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,558,200
Market Cap $9.39M
Description
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.